A detailed history of Mesirow Institutional Investment Management, Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Mesirow Institutional Investment Management, Inc. holds 89,382 shares of FOLD stock, worth $753,490. This represents 0.07% of its overall portfolio holdings.

Number of Shares
89,382
Previous 81,752 9.33%
Holding current value
$753,490
Previous $873,000 3.67%
% of portfolio
0.07%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$9.36 - $12.01 $71,416 - $91,636
7,630 Added 9.33%
89,382 $841,000
Q3 2024

Nov 13, 2024

BUY
$9.55 - $12.09 $419,951 - $531,645
43,974 Added 116.4%
81,752 $873,000
Q2 2024

Aug 02, 2024

BUY
$9.04 - $11.75 $55,858 - $72,603
6,179 Added 19.55%
37,778 $374,000
Q1 2024

May 06, 2024

BUY
$11.43 - $14.24 $361,176 - $449,969
31,599 New
31,599 $372,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.36B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Mesirow Institutional Investment Management, Inc. Portfolio

Follow Mesirow Institutional Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Institutional Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Institutional Investment Management, Inc. with notifications on news.